FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

Vaccines and Related Biological Products Advisory Committee

horizontal rule

February 17, 2006 Meeting

Date and Time:

The meeting will be held via teleconference on February 17, 2006; 1:00 p.m. to 5:30 p.m.

Location:

NIH Campus, Food and Drug Administration, Bldg. 29B, Conference Room A & B, 8800 Rockville Pike, Bethesda, MD. This meeting will be held by a teleconference. The public is welcome to attend at the above location. A speakerphone will be provided at the specified location for public participation in this meeting. Important information about transportation and directions to the NIH Campus, parking, and security procedures is available on the internet at http://www.nih.gov/about/visitor/index.htm.

Contact Persons:

Christine Walsh, R.N. or Denise Royster, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512391. Please call the Information Line for up-to-date information on this meeting.

Agenda:

The committee will review and discuss the selection of strains to be included in the influenza virus vaccine for the 2006 – 2007 season.

Oral Presentations:

Between approximately 3:30 and 4:30 p.m. oral presentations from the public will be scheduled. Those desiring to make formal oral presentations should notify the contact person before February 10, 2006.

 

 
horizontal rule